<DOC>
	<DOCNO>NCT00605085</DOCNO>
	<brief_summary>The objective investigate safety tolerability Japanese Encephalitis vaccine IC51 inactive control healthy subject age &gt; = 18 year</brief_summary>
	<brief_title>Safety Tolerability Japanese Encephalitis Vaccine IC51</brief_title>
	<detailed_description />
	<mesh_term>Encephalitis</mesh_term>
	<mesh_term>Encephalitis , Japanese</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>At least 18 year age Written inform consent obtain prior study entry Use investigational nonregistered drug vaccine addition study vaccine study period within 30 day precede first dose study vaccine History previous JE vaccination ( e.g . JEVAXÂ® ) Immunodeficiency include postorgantransplantation immunosuppressive therapy A family history congenital hereditary immunodeficiency History autoimmune disease Any acute infection within 2 week prior enrollment Known suspect HIV Infection Pregnancy , lactation unreliable contraception female subject</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>